pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Phase 1
    IKS-03
    B-Cell Non-Hodgkin Lymphoma Iksuda Therapeutics Ltd
  • Preclinical
    IKS-04
    Bile Duct Cancer (Cholangiocarcinoma) Iksuda Therapeutics Ltd
  • Preclinical
    IL-2 + imiquimod
    imiquimod
    Solid Tumor Activate Therapeutics LLC
  • Preclinical
← prev
page 107 of 271
next →
Pain89
Neurology1
IL-2106
Gastric Cancer
iLEAD Biomedical Science Inc
  • Preclinical
    IL-21120033
    Idiopathic Pulmonary Fibrosis iLEAD Biomedical Science Inc
  • Phase 2
    IM-101
    Myasthenia Gravis ImmunAbs Inc
  • Phase 1
    IM-1021
    Diffuse Large B-Cell Lymphoma$IMNM Immunome Inc.
  • Preclinical
    IM-1240
    Adenocarcinoma Of The Gastroesophageal Junction$PPBT PURPLE BIOTECH LTD.
  • Phase 1
    IM-3050
    Solid Tumor$IMNM Immunome Inc.
  • Phase 2
    IMA-203CD8
    Solid Tumor Immatics NV
  • IMATINIB
    IMATINIB
    no indication DR REDDYS
  • Phase 2
    IMB-101
    Hidradenitis Suppurativa Navigator Medicines Inc
  • Phase 1
    IMC-002
    Solid Tumor ImmuneOncia Therapeutics Inc
  • Preclinical
    IMC-008
    Gastric Cancer Suzhou Immunofoco Biotechnology Co Ltd
  • IMCIVREE
    IMCIVREE (SETMELANOTIDE ACETATE)
    1 INDICATIONS AND USAGE IMCIVREE is indicated to reduce e…$RYTM RHYTHM PHARMACEUTICALS, INC.
  • IMDELLTRA
    IMDELLTRA (TARLATAMAB-DLLE)
    1 INDICATIONS AND USAGE IMDELLTRA is indicated for the tr…$AMGN AMGEN INC
  • Phase 2
    IMG-007
    Atopic Dermatitis (Atopic Eczema)$IMA ImageneBio, Inc.
  • IMITREX
    IMITREX (SUMATRIPTAN SUCCINATE)
    no indication GlaxoSmithKline LLC
  • IMITREX STATDOSE
    IMITREX STATDOSE (SUMATRIPTAN SUCCINATE)
    no indication GlaxoSmithKline LLC
  • IMKELDI
    IMKELDI (IMATINIB ORAL)
    no indication Shorla Oncology
  • Preclinical
    IMM-004
    Sickle Cell Disease IMMvention Therapeutix Inc
  • Phase 2
    IMM-124E
    Travelan
    Traveler's Diarrhea$IMRN Immuron Ltd
  • Preclinical
    IMM-4701
    Triple-Negative Breast Cancer (TNBC) ImmuneOnco Biopharmaceuticals (Shanghai) Co Ltd
  • Phase 2
    IMM01-STEM
    Muscle Atrophy Immunis Inc
  • Phase 3
    IMNN-001
    Epithelial Ovarian Cancer$IMNN Imunon, Inc.
  • Phase 2
    IMNN-101
    Coronavirus Disease 2019 (COVID-19)$IMNN Imunon, Inc.
  • Phase 2
    IMP-1734
    Fallopian Tube Cancer$EIKN Eikon Therapeutics, Inc.
  • Phase 2
    IMP-9064
    Solid Tumor IMPACT Therapeutics Inc
  • IMPLANON
    IMPLANON (ETONOGESTREL)
    HIV infection$OGN Organon & Co.
  • Phase 2
    IMS-001
    Primary Progressive Multiple Sclerosis (PPMS) Imstem Biotechnology Inc